COLTENE Holding Resultados de beneficios anteriores

Pasado controles de criterios 2/6

COLTENE Holding ha aumentado sus beneficios a una tasa media anual de 1.4%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 10.6% anual. Los ingresos han ido disminuyendo a una tasa media de 0.8% al año. La rentabilidad financiera de COLTENE Holding es de 12.3%, y sus márgenes netos son de 5.2%.

Información clave

1.4%

Tasa de crecimiento de los beneficios

0.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	11.1%
Tasa de crecimiento de los ingresos	-0.8%
Rentabilidad financiera	12.3%
Margen neto	5.2%
Próxima actualización de resultados	07 Mar 2025

Actualizaciones de resultados anteriores recientes

Recent updates

Earnings Update: COLTENE Holding AG (VTX:CLTN) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Mar 13

COLTENE Holding AG's (VTX:CLTN) Business And Shares Still Trailing The Market

Jan 21

At CHF83.10, Is COLTENE Holding AG (VTX:CLTN) Worth Looking At Closely?

Jun 15

COLTENE Holding AG (VTX:CLTN) Analysts Are Pretty Bullish On The Stock After Recent Results

Mar 08

Is COLTENE Holding AG's (VTX:CLTN) Shareholder Ownership Skewed Towards Insiders?

Jan 11

Does COLTENE Holding (VTX:CLTN) Have A Healthy Balance Sheet?

Dec 17

Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?

Dec 03

COLTENE Holding's (VTX:CLTN) Shareholders Are Down 25% On Their Shares

Nov 20

Shorn Like A Sheep: Analysts Just Shaved Their COLTENE Holding AG (VTX:CLTN) Forecasts Dramatically

Jun 22

Desglose de ingresos y gastos

Cómo gana y gasta dinero COLTENE Holding. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

SWX:CLTN Ingresos, gastos y beneficios (CHF Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	239	12	97
31 Mar 24	241	12	97
31 Dec 23	243	12	97
30 Sep 23	253	18	98
30 Jun 23	264	24	100
31 Mar 23	265	25	101
31 Dec 22	267	26	102
30 Sep 22	269	26	103
30 Jun 22	271	26	103
31 Mar 22	275	29	103
31 Dec 21	279	32	102
30 Sep 21	284	29	100
30 Jun 21	288	26	97
31 Mar 21	268	17	94
31 Dec 20	248	8	92
30 Sep 20	245	10	98
30 Jun 20	242	12	104
31 Mar 20	258	16	108
31 Dec 19	274	20	111
30 Sep 19	264	19	106
30 Jun 19	254	19	100
31 Mar 19	229	18	91
31 Dec 18	204	17	82
30 Sep 18	190	18	77
30 Jun 18	176	19	71
31 Mar 18	172	19	70
31 Dec 17	168	19	68
30 Sep 17	166	18	67
30 Jun 17	163	16	66
31 Mar 17	162	17	66
31 Dec 16	161	17	65
30 Sep 16	159	17	64
30 Jun 16	157	17	63
31 Mar 16	156	15	63
31 Dec 15	155	13	62
30 Sep 15	157	14	64
30 Jun 15	160	14	65
31 Mar 15	161	15	65
31 Dec 14	162	16	65
30 Sep 14	162	15	60
30 Jun 14	161	14	56
31 Mar 14	161	13	57
31 Dec 13	160	13	57

Ingresos de calidad: CLTN tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(5.2%) de CLTN son inferiores a los del año pasado (9.1%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de CLTN han crecido un 1.4% al año en los últimos 5 años.

Acelerando crecimiento: CLTN ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: CLTN tuvo un crecimiento negativo de los beneficios (-48.3%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (2.9%).

COLTENE Holding Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

First half 2024 earnings released: EPS: CHF1.74 (vs CHF1.68 in 1H 2023)

Full year 2023 earnings released: EPS: CHF2.00 (vs CHF4.35 in FY 2022)

COLTENE Holding AG to Report Fiscal Year 2024 Results on Mar 07, 2025

First half 2023 earnings released: EPS: CHF1.68 (vs CHF2.03 in 1H 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

First half 2022 earnings released

Recent updates

Consensus EPS estimates fall by 12%

First half 2024 earnings released: EPS: CHF1.74 (vs CHF1.68 in 1H 2023)

New minor risk - Share price stability

Upcoming dividend of CHF2.00 per share

Consensus EPS estimates increase by 17%

Earnings Update: COLTENE Holding AG (VTX:CLTN) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Full year 2023 earnings released: EPS: CHF2.00 (vs CHF4.35 in FY 2022)

Dividend of CHF2.00 announced

COLTENE Holding AG to Report Fiscal Year 2024 Results on Mar 07, 2025

New minor risk - Financial data availability

Consensus EPS estimates fall by 29%

COLTENE Holding AG's (VTX:CLTN) Business And Shares Still Trailing The Market

Consensus EPS estimates fall by 21%

Investor sentiment deteriorates as stock falls 17%

Coltene Holding Ag Provides Sales Guidance for the Financial Year 2023

New minor risk - Share price stability

New minor risk - Share price stability

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 18%

First half 2023 earnings released: EPS: CHF1.68 (vs CHF2.03 in 1H 2022)

Now 21% undervalued after recent price drop

Upcoming dividend of CHF3.30 per share at 4.4% yield

Full year 2022 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

First half 2022 earnings released

COLTENE Holding AG Provides Earnings Guidance for the First Half and Full Year of Fiscal 2022

At CHF83.10, Is COLTENE Holding AG (VTX:CLTN) Worth Looking At Closely?

Price target increased to CHF105

Insufficient new directors

COLTENE Holding AG Approves the Distribution, Payable on 27 April 2022

Upcoming dividend of CHF3.30 per share

COLTENE Holding AG (VTX:CLTN) Analysts Are Pretty Bullish On The Stock After Recent Results

Should You Investigate COLTENE Holding AG (VTX:CLTN) At CHF88.90?

COLTENE Holding AG to Report First Half, 2023 Results on Aug 04, 2023

Full year 2021 earnings: EPS misses analyst expectations

Is COLTENE Holding (VTX:CLTN) Using Too Much Debt?

Insufficient new directors

Insufficient new directors

Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?

First half 2021 earnings released: EPS CHF3.04 (vs CHF0.05 in 1H 2020)

COLTENE Holding AG Provides Earnings Guidance for the First Half and Full Year of Fiscal 2021

COLTENE Holding (VTX:CLTN) Has A Pretty Healthy Balance Sheet

Price target increased to CHF101

How Does COLTENE Holding AG (VTX:CLTN) Fare As A Dividend Stock?

Upcoming dividend of CHF3.00 per share

Is Now The Time To Look At Buying COLTENE Holding AG (VTX:CLTN)?

Analysts increase EPS estimates to CHF5.42

Revenue beats expectations, earnings disappoint

Full year 2020 earnings released: EPS CHF1.38 (vs CHF3.35 in FY 2019)

COLTENE Holding AG to Report First Half, 2022 Results on Aug 05, 2022

Shareholders Of COLTENE Holding (VTX:CLTN) Must Be Happy With Their 84% Return

New 90-day high: CHF108

Is COLTENE Holding AG's (VTX:CLTN) ROE Of 16% Impressive?

New 90-day high: CHF93.50

New 90-day high: CHF86.60

Is COLTENE Holding AG's (VTX:CLTN) Shareholder Ownership Skewed Towards Insiders?

Investor sentiment improved over the past week

Analysts increase EPS estimates to CHF1.67

An unknown buyer agreed to acquire Vigodent SA Industria e Comércio from COLTENE Holding AG (SWX:CLTN) for CHF 12 million.

Does COLTENE Holding (VTX:CLTN) Have A Healthy Balance Sheet?

New 90-day high: CHF78.30

Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?

COLTENE Holding's (VTX:CLTN) Shareholders Are Down 25% On Their Shares

New 90-day low: CHF70.00

Price target lowered to CHF74.00

Earnings released

Shorn Like A Sheep: Analysts Just Shaved Their COLTENE Holding AG (VTX:CLTN) Forecasts Dramatically

Desglose de ingresos y gastos

Historial de beneficios e ingresos